Chimeric Therapeutics Ltd banner

Chimeric Therapeutics Ltd
ASX:CHM

Watchlist Manager
Chimeric Therapeutics Ltd Logo
Chimeric Therapeutics Ltd
ASX:CHM
Watchlist
Price: 0.165 AUD -17.5% Market Closed
Market Cap: AU$8.6m

Wall St Price Targets

CHM Price Targets Summary
Chimeric Therapeutics Ltd

There are no price targets for CHM.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Chimeric Therapeutics Ltd Competitors:
Price Targets
QNST
Quinstreet Inc
52% Upside
APA
APA Corp (US)
1% Upside
UFPT
UFP Technologies Inc
71% Upside
ACIU
AC Immune SA
208% Upside
CALM
Cal-Maine Foods Inc
16% Upside
AREC
American Resources Corp
168% Upside
TARA
Protara Therapeutics Inc
389% Upside
CSGP
CoStar Group Inc
71% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHM's stock price target?
Not Available

CHM does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett